Skip to main content
. 2017 Feb 17;215(9):1362–1365. doi: 10.1093/infdis/jix089

Table 2.

Projected Impact of HIVDR on AIDS Deaths, New Infections, and ART Costs in Sub–Saharan Africa 2016–2030.a

AIDS Deaths New Infections ART Costs
With HIVDR
(Fast-track projections)
5.6 million 5.1 million $ 83 billion
Current level of PDR <10%
Percentage attributable to HIVDR 13% 7% 6%
Amount attributable to HIVDR 710,000 380 000 $5.0 billion
Current level of PDR ≥10%
Percentage attributable to HIVDR 16% 9% 8%
Amount attributable to HIVDR 890 000 450 000 $6.5 billion

Abbreviations: HIV, human immunodeficiency virus; HIVDR, HIV drug resistance; PDR, pretreatment HIV drug resistance.

aUsing the Spectrum Goals Model estimates [6] by applying the impact of drug resistance as estimated using the HIV Synthesis Model.